Mixed reactions to latest coronary stenting study

Published date : 30 August 2012
Article date : 30 August 2012

More findings and analysis from St. Jude Medical's Fame II trial, studying fractional flow reserve-directing coronary stenting, have been made available.

According to the manufacture, patients who received percutaneous coronary intervention in addition to drug therapy were better off than patients who took drugs alone. However, a Mass Device article reports that some questions on the results have been raised in the market place. 

The article goes on to say that patients in one area of the study received percutaneous coronary intervention guided by fractional flow reserve technology to measure and identify blood vessel narrowings and determine which are obstructing blood flow to the heart. Those patients also received "optimal medical therapy," an anti-platelet and beta blocker drug regimen.

Source: Mass Device, 28th August 2012

Read the full article here

Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.